ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
70.795
-0.22%
US Dollar vs AUD
1.44593
-0.34%
Bitcoin
65,735.21
0.85%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anavex Life Sciences Corporation (AVXL)

  7. Anavex Life Sciences Corporation (AVXL) News

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVXL
DateTimeSourceHeadlineSymbolCompany
03/09/202421:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024NASDAQ:AVXLAnavex Life Sciences Corporation
07/08/202407:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
06/08/202421:30GlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
01/08/202421:30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
31/07/202407:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVXLAnavex Life Sciences Corporation
30/07/202421:30GlobeNewswire Inc.Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
30/07/202407:21Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AVXLAnavex Life Sciences Corporation
29/07/202407:00GlobeNewswire Inc.Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
20/06/202421:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
17/06/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
22/05/202421:30GlobeNewswire Inc.Anavex Life Sciences Announces Expansion of Leadership TeamNASDAQ:AVXLAnavex Life Sciences Corporation
17/05/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
17/05/202420:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
14/05/202421:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQNASDAQ:AVXLAnavex Life Sciences Corporation
10/05/202419:45PR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:AVXLAnavex Life Sciences Corporation
10/05/202406:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
09/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVXLAnavex Life Sciences Corporation
09/05/202421:30GlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
07/05/202419:45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) ShareholdersNASDAQ:AVXLAnavex Life Sciences Corporation
06/05/202420:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVXLAnavex Life Sciences Corporation
03/05/202419:45PR Newswire (US)Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/05/202421:30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
26/04/202419:45PR Newswire (US)May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
19/04/202419:45PR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
16/04/202419:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
12/04/202419:45PR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
11/04/202421:30GlobeNewswire Inc.Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
09/04/202419:45PR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
05/04/202420:45PR Newswire (US)Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/04/202420:45PR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL

Your Recent History

ASX
WBC
Westpac Banking
ASX
SUN
Suncorp
NASDAQ
MSFT
Microsoft
ASX
WDC
Westfield
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
RIO
Rio Tinto
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
ASX
BHP
BHP
ASX
XJO
S&P ASX 200
COIN
XRPUSD
Ripple
COIN
DOGEUSD
Dogecoin
ASX
ORG
Origin Energy
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved